Home / Solutions
Solutions

Missing patients cost every team. Find your fix.

Delayed enrollment, amended protocols, launches that miss the people they're for. Pick your team and see where community intelligence changes the outcome.

For R&D & clinical teams · Study design

Design for representation before the protocol is locked.

Bring community intelligence into protocol, eligibility and visit-burden decisions, so studies reflect the intended-use population.

The decisions that limit participation are made months before enrollment.

Protocols and site plans are locked without insight into the communities that need to be represented.
Eligibility, visit burden and access barriers land differently across populations, and surface later as screen failures and stalls.
Recruitment vendors are brought in at the finish line to patch gaps that were designed in.

What your team gets

Protocol fit & burden review
See which eligibility criteria, visit schedules and procedures communities name as barriers, before the protocol is locked.
Population-informed site strategy
Place sites where the intended-use population lives and is ready to participate, not by prevalence alone.
Population-specific access plans
Evidence-based access interventions matched to each population's preferences, burden and access.
Metrics AVA movesReflectiveness vs. intended-use populationProtocol amendments avoidedTime to Last Patient InScreen-fail ratioSite activation velocity
For R&D & clinical teams · Site strategy & feasibility

Choose sites by readiness, not geography alone.

Before site lists are locked, see whether nearby communities are ready to take part, and stay connected through NOWINCLUDED.

Capacity is not the same as community readiness.

Feasibility questionnaires measure site capacity, not community willingness.
Sites in the right zip codes still underperform when trust is low.
Site and community relationships end when the study does.

What your team gets

Community readiness by site
See trust, willingness and barriers for the communities each site serves.
Site engagement tracking
Follow events, referrals and on-site screening delivered around every site.
Site engagement support
Hands-on NOWINCLUDED engagement scoped to your active sites, adjusted as sites change.
Metrics AVA movesSite activation velocityEnrollment per siteReferral-to-screen ratePopulation reflectiveness across sites
Where we're active

Trust is local. We're already there.

NOWINCLUDED is active in 19 metros, with 9 more planned. That footprint means faster enrollment, stronger representation and lower trial risk.

300+
community activations moving people from awareness to engagement to action
104M
authenticated community data points informing trial strategy
Activated metro
Planned activation
Home metros
Check coverage for your study →

Activated (19)

  • Atlanta
  • Baltimore
  • Birmingham
  • Boston
  • Charlotte
  • Chicago
  • Dallas
  • Detroit
  • Houston
  • Huntsville
  • Los Angeles
  • Miami
  • Mobile
  • Nashville
  • New Orleans
  • New York City
  • Philadelphia
  • Sacramento
  • Washington, DC

Planned (9)

  • Cleveland
  • Denver
  • Hartford
  • Memphis
  • Minneapolis
  • Orlando
  • San Diego
  • St. Louis
  • Tampa
For health equity & advocacy teams · Patient & community engagement

Patient voice at scale, all year long.

Hear communities in their own words, continuously, from study design through launch.

A few voices, once, is not patient voice.

Advisory boards capture a few voices at a single moment.
Feedback rarely reaches protocols and materials in time to change them.
Communities hear nothing back once a study ends.

What your team gets

Insights in members' own words
Survey and comment data from authenticated NOWINCLUDED members, filterable by topic.
Culturally competent materials
Co-design education and outreach with the community before launch.
Results shared back
Close the loop with communities through NOWINCLUDED channels.
Metrics AVA movesSustained community reachMaterial approval ratesPatient journey retentionCommunity trust over time
For commercial teams · Commercial & TA strategy

Understand the barriers shaping your market before and after launch.

Focus groups give you snapshots. AVA gives you longitudinal insight from a 315K+ network, and NOWINCLUDED keeps engaging those communities after approval.

You can see adoption lag. You cannot see why.

No visibility into why specific populations delay, reject or drop off therapies.
Unbranded education spend that does not move health literacy or activation.
Communities engaged in development are lost by launch, so trust has to be rebuilt from zero.

What your team gets

Pre-launch population readiness
Trust, beliefs and barriers in your launch markets, by metro and cohort.
Patient journey & unbranded campaign analytics
See which messages and channels move people from awareness to action.
Longitudinal barrier mapping
Follow how care-pathway barriers change over time.
Metrics AVA movesUnbranded activation ratePatient journey conversionPre-launch readinessHealth literacy improvement
For health equity & advocacy teams · Impact measurement & RWE

Make the impact of your work impossible to overlook.

Health equity teams are asked to show what their work changed. AVA measures community trust, reach and participation over time, by population and metro, so you can report progress with first-party evidence instead of activity counts.

Good work goes unseen when it can't be measured.

Equity work gets reported as activity, not as a change in trust or participation.
Short-term outreach that vanishes after a trial ends erodes the trust it is meant to build.
Teams lack population-specific, pre-protocol evidence on preferences, burden and access.

What your team gets

Impact reporting you can share
AVA's Project Overview and Community Engagement views show the work delivered and the health actions completed, by metro and channel, backed by year-round NOWINCLUDED engagement.
Quantifiable trust & readiness scoring
Community Trust Index, willingness and barriers by population and metro.
Population-specific evidence
First-party RWD on preferences, burden and access by population and metro, ready to inform design and regulatory conversations.
Metrics AVA tracksLongitudinal Community Trust IndexReflectiveness vs. intended-use populationAwareness-to-willingness conversionPortfolio reflectiveness index
For CROs · CRO partnerships

Win the bid. Design it to deliver.

Back representation commitments with evidence from day one, with NOWINCLUDED ready to activate in your sponsor's metros.

Sponsors want commitments backed by evidence.

Sponsors expect population reflectiveness backed by data, not intentions.
Representation gaps found mid-study are expensive to close.
Recruitment vendors add cost without visibility into what is working.

What your team gets

Feasibility evidence for proposals
Community readiness by metro to support bids and representation plans.
In-study diagnostics
Find out whether stalls come from sites, protocol fit or trust.
Shared sponsor dashboards
One AVA view for CRO and sponsor teams.
Metrics AVA movesProtocol amendments avoidedScreen-fail ratioPopulation reflectiveness
For community organizations · Community partners

Bring research opportunities and resources to your community.

Faith, civic and health organizations partner with NOWINCLUDED to bring education, events and research opportunities to their communities.

Research too often comes and goes.

Communities are approached when a study needs them, then hear nothing back.
Local organizations carry the trust but rarely get the resources to act on it.
Health information arrives without the cultural context that makes it useful.

What your organization gets

Co-hosted events and education
Health walks, screenings and conversations planned with you, in your community.
A voice in how research shows up
Shape the questions, materials and engagement before a study launches.
Results shared back
Findings return to the community that made them possible.

Not sure which fits your program?

Tell us your therapeutic area and timeline. We'll show you where people are and what it takes to reach them.